NEC2022-03-09T11:19:17-05:00

Has Your Child Been Affected By Necrotizing Enterocolitis, Also Known as NEC?

Necrotizing enterocolitis (NEC) is a devastating disease that affects the intestines of premature infants. NEC in babies typically occurs in infants born before 38 weeks gestation and develops between 2 to 4 weeks after birth.

The risk of NEC in babies is significantly heightened when fed specific cow-milk-based formulas.

In these instances, the wall of the intestines is invaded by bacteria, and it erodes the intestinal lining until holes form and causes the risk of infection. While some infants who survive NEC grow up to lead everyday lives, others have significant health problems stemming from their NEC diagnosis. Severe cases of NEC are life-threatening. About 1 in 4 babies diagnosed with NEC need surgery to remove dead intestinal tissue and repair holes in the intestines.

Studies have consistently shown that cow’s milk-based baby formula products, mainly Similac and Enfamil products manufactured by Abbott and Mead Johnson, cause an increased risk of dangerous digestive disease, including NEC. As far back as 1990, a study found that NEC was 6 to 10 times more common in formula-fed babies than in those fed breast milk alone, and NEC was three times more common in babies fed formula plus breast milk.

In 2012, the American Academy of Pediatrics issued a policy statement that all premature infants should be fed an exclusive human milk diet because of the risk of NEC associated with the consumption of cow’s milk-based products. Despite their early knowledge of this increased risk, the manufacturers failed to warn parents of the risk of NEC and failed to place warnings on their products.

  • Which Baby Formulas are Linked to NEC?

    • Similac Special Care 20, 24 and 30
    • Similac NeoSure
    • Similac Special Care 24 – High Protein
    • Similac Liquid Protein Fortifier
    • Similac Alimentum Formulas
    • Enfamil Human Milk Fortifier
    • Enfamil NeuroPro EnfaCare
    • Enfamil 24 Cal
    • Enfamil Premature 20 Cal, 24 Cal, and 30 Cal
  • What are the Symptoms of NEC in Children?

    • Abdominal pain and swelling
    • Diarrhea with bloody stool
    • Poor feeding or feeding intolerance
    • Vomiting
    • Lethargy
    • Slow or abnormal breathing

    Fever

Why Should You Chose Berger Montague 

How Do I Know If I Qualify for an NEC Formula Lawsuit?

Berger Montague represents parents of premature infants who were fed cow’s milk-based infant formula in the neonatal intensive care units (NICU) and subsequently developed NEC.

If your premature infant developed NEC after receiving cow’s milk-based baby formula in the NICU or hospital, you might qualify for legal action.

Contact us for a free legal consultation.

Want to schedule a free consultation?

Request Free Consultation

Meet the Attorneys 

Shanon Carson Headshot


Shanon Carson

Shanon J. Carson is an Executive Shareholder of the Firm. He Chair’s the Firm’s Mass Tort, Defective Products, and Defective Drugs and Medical Devices Departments, serves in court-appointed leadership positions in major litigation across the United States, is recognized as one of the top litigators in the country, and has received honors and awards from numerous publications.


Dena Young

Dena Young is Senior Counsel in the Firm’s Consumer Protection practice group. She concentrates her practice in the area of complex consumer litigation representing individuals who have been injured by dangerous drugs, medical devices, and defective products. Ms. Young serves on the Plaintiffs’ Steering Committee of the Allergan Biocell Textured Breast Implant Products Liability Litigation and has previously litigated claims involving Johnson & Johnson Talcum Powder, Xarelto, Risperdal, Transvaginal Mesh, and Roundup.


Najah Jacobs

Ms. Jacobs is an Associate in the Firm’s Philadelphia office and practices in the Firm’s Consumer Protection and Employee Benefits & ERISA practice groups. Before joining the Firm, Ms. Jacobs was an associate at a Philadelphia law firm, where she focused her practice on commercial litigation matters.


Peter A. Muhic

Peter A. Muhic is a Shareholder located at the Philadelphia Office. He has substantial experience litigating significant claims, including for wrongful death, personal injuries and economic losses, throughout the country against manufacturers and suppliers of defective products. Mr. Muhic’s experience carries through all phases of litigation, from case initiation through trial and appeals.

 

Awards and Recognition 

Let’s work together.

We work as a single united team with market leading firms around the world and give our clients the highest quality advice possible.

Contact Us